Patent · US Active

Prediction of recurrence for bladder cancer by a protein signature in tissue samples

US10809261B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignees

Deutsches Krebsforschungszentrum · DE
INSTITUT CURIE · FR

Inventors

Christoph Schröder · Heidelberg, DE
Harish Srinivasan · Sammamish, US
Jorg Hoheisel · Wiesbaden, DE
Francois Radvanyi · Fontenay-aux-Roses, FR

Key dates

Filing date	May 8, 2017
Grant date	Oct 20, 2020
Priority date	—
Expiry date	Jan 27, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/56
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention pertains to the field of cancer prediction. Specifically, it relates to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment of bladder cancer comprising the steps of determining the amount of at least one biomarker selected from the biomarkers shown in Table, and comparing the amount of said at least one biomarker with a reference amount for said at least one biomarker, whereby the risk of recurrence of bladder cancer is to be predicted. The present invention also contemplates a method for identifying a subject being in need of a further bladder cancer therapy. Encompassed are, furthermore, diagnostic devices and kits for carrying out said methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.